Literature DB >> 6743335

Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes.

R N Pinckard, E M Jackson, C Hoppens, S T Weintraub, J C Ludwig, L M McManus, G E Mott.   

Abstract

The molecular heterogeneity of platelet-activating factor (PAF) produced by stimulated human neutrophilic polymorphonuclear leukocytes (PMN) was assessed by both normal and reverse phase high performance liquid chromatography (HPLC). As detected by rabbit platelet stimulation, at least 5 PAF molecules were separated by HPLC. Fast atom bombardment (FAB) mass spectrometry revealed one of these PAFs was acetyl glyceryl ether phosphorylcholine (AGEPC) with a C16:0 alkyl chain in the sn-1 position. Although the structures of the remaining PAFs are unknown, two of the peaks of PAF activity had the same retention times on reverse phase HPLC as the C15- and C18-saturated alkyl chain AGEPC homologues. These studies indicate that the human PMN produces multiple molecular species of PAF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743335     DOI: 10.1016/0006-291x(84)90478-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Structural and (patho)physiological diversity of PAF.

Authors:  R N Pinckard; D S Woodard; H J Showell; M J Conklyn; M J Novak; L M McManus
Journal:  Clin Rev Allergy       Date:  1994

2.  1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes.

Authors:  K Satouchi; M Oda; K Saito
Journal:  Lipids       Date:  1987-04       Impact factor: 1.880

3.  Determination of the platelet activating factor in silicotic patients and its effect on fibroblasts.

Authors:  Q Zhang; Y Mo; J Lou; X Zhu; Z Chen; L He; H Zhong
Journal:  Environ Health Prev Med       Date:  2001-01       Impact factor: 3.674

4.  Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.

Authors:  T Mózes; F J Zijlstra; J P Heiligers; C J Tak; S Ben-Efraim; I L Bonta; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

5.  Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.

Authors:  J G Filep; F Hermán; E Földes-Filep; F Schneider; P Braquet
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

6.  Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils.

Authors:  M Triggiani; R P Schleimer; K Tomioka; W C Hubbard; F H Chilton
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

7.  Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress.

Authors:  J Sugatani; K Fujimura; M Miwa; K Satouchi; K Saito
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.